MX2007013470A - Forma purificada de tanaproget. - Google Patents
Forma purificada de tanaproget.Info
- Publication number
- MX2007013470A MX2007013470A MX2007013470A MX2007013470A MX2007013470A MX 2007013470 A MX2007013470 A MX 2007013470A MX 2007013470 A MX2007013470 A MX 2007013470A MX 2007013470 A MX2007013470 A MX 2007013470A MX 2007013470 A MX2007013470 A MX 2007013470A
- Authority
- MX
- Mexico
- Prior art keywords
- tanaproget
- purified form
- prepared
- forms
- purified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proveen tanaproget micronizado, forma I purificada de tanaproget, y forma I purificada, micronizada de tanaproget; tambien se proveen composiciones que contienen una o mas de las formas de tanaproget preparado, metodos de uso de una o mas de las formas de tanaproget preparado, y equipos que contienen una o mas de las formas de tanaproget preparado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67573805P | 2005-04-28 | 2005-04-28 | |
PCT/US2006/015813 WO2006116498A2 (en) | 2005-04-28 | 2006-04-26 | Purified form of tanaproget |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007013470A true MX2007013470A (es) | 2008-01-22 |
Family
ID=37000404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007013470A MX2007013470A (es) | 2005-04-28 | 2006-04-26 | Forma purificada de tanaproget. |
Country Status (14)
Country | Link |
---|---|
US (1) | US7786297B2 (es) |
EP (1) | EP1874743B1 (es) |
JP (2) | JP2008539254A (es) |
CN (1) | CN101184738B (es) |
AR (1) | AR053595A1 (es) |
AU (1) | AU2006241189B2 (es) |
BR (1) | BRPI0610156A2 (es) |
CA (1) | CA2603786A1 (es) |
ES (1) | ES2431324T3 (es) |
GT (1) | GT200600173A (es) |
MX (1) | MX2007013470A (es) |
PE (1) | PE20061322A1 (es) |
TW (1) | TW200716130A (es) |
WO (1) | WO2006116498A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101166533A (zh) * | 2005-04-28 | 2008-04-23 | 惠氏公司 | 微粉化的tanaproget和含有它的组合物 |
DE602006007453D1 (de) | 2005-04-28 | 2009-08-06 | Wyeth Corp | Zusammensetzungen mit mikronisiertem tanaproget |
US7767668B2 (en) * | 2005-04-28 | 2010-08-03 | Wyeth Llc | Micronized tanaproget, compositions, and methods of preparing the same |
BRPI0610433A2 (pt) * | 2005-04-28 | 2010-11-23 | Wyeth Corp | forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada |
CA2610767C (en) | 2005-06-09 | 2014-09-23 | Wyeth | Tanaproget compositions containing ethinyl estradiol |
JP2011507853A (ja) | 2007-12-20 | 2011-03-10 | テバ ウィメンズ ヘルス インコーポレイテッド | 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ |
WO2014143617A1 (en) * | 2013-03-14 | 2014-09-18 | Teva Women's Health, Inc. | Deuterium-enriched tanaproget and processes for its preparation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01011287A (es) * | 1999-05-04 | 2003-07-14 | American Home Prod | Derivados de ciclotiocarbamato como moduladores de receptor de progesterona. |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
JP2005535628A (ja) | 2002-06-25 | 2005-11-24 | ワイス | Prモジュレーターとしてのシクロチオカルバメート誘導体 |
JP2005535624A (ja) | 2002-06-25 | 2005-11-24 | ワイス | ホルモン関連症状の治療におけるシクロチオカルバメート誘導体の使用 |
CN1953967B (zh) | 2004-04-27 | 2013-03-13 | 惠氏公司 | 孕酮受体调节剂的纯化 |
AR049631A1 (es) * | 2004-04-27 | 2006-08-23 | Wyeth Corp | Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos |
JP4980217B2 (ja) | 2004-08-13 | 2012-07-18 | ワイス・エルエルシー | タナプロゲト誘導体、代謝産物、及びそれらの使用 |
-
2006
- 2006-04-26 US US11/412,016 patent/US7786297B2/en not_active Expired - Fee Related
- 2006-04-26 BR BRPI0610156A patent/BRPI0610156A2/pt not_active IP Right Cessation
- 2006-04-26 CA CA002603786A patent/CA2603786A1/en not_active Abandoned
- 2006-04-26 PE PE2006000439A patent/PE20061322A1/es not_active Application Discontinuation
- 2006-04-26 JP JP2008509080A patent/JP2008539254A/ja not_active Withdrawn
- 2006-04-26 GT GT200600173A patent/GT200600173A/es unknown
- 2006-04-26 CN CN2006800142326A patent/CN101184738B/zh not_active Expired - Fee Related
- 2006-04-26 EP EP06769890.2A patent/EP1874743B1/en not_active Not-in-force
- 2006-04-26 ES ES06769890T patent/ES2431324T3/es active Active
- 2006-04-26 MX MX2007013470A patent/MX2007013470A/es active IP Right Grant
- 2006-04-26 AU AU2006241189A patent/AU2006241189B2/en not_active Ceased
- 2006-04-26 WO PCT/US2006/015813 patent/WO2006116498A2/en active Application Filing
- 2006-04-26 AR ARP060101667A patent/AR053595A1/es not_active Application Discontinuation
- 2006-04-26 TW TW095114815A patent/TW200716130A/zh unknown
-
2013
- 2013-06-12 JP JP2013123477A patent/JP2013231042A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2008539254A (ja) | 2008-11-13 |
TW200716130A (en) | 2007-05-01 |
ES2431324T3 (es) | 2013-11-26 |
WO2006116498A2 (en) | 2006-11-02 |
AU2006241189B2 (en) | 2012-01-19 |
AR053595A1 (es) | 2007-05-09 |
PE20061322A1 (es) | 2006-12-28 |
US20060247236A1 (en) | 2006-11-02 |
CN101184738A (zh) | 2008-05-21 |
AU2006241189A1 (en) | 2006-11-02 |
CA2603786A1 (en) | 2006-11-02 |
GT200600173A (es) | 2006-11-22 |
BRPI0610156A2 (pt) | 2016-08-16 |
JP2013231042A (ja) | 2013-11-14 |
EP1874743A2 (en) | 2008-01-09 |
WO2006116498A3 (en) | 2006-12-14 |
US7786297B2 (en) | 2010-08-31 |
CN101184738B (zh) | 2012-05-23 |
EP1874743B1 (en) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
ATE548374T1 (de) | 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren | |
MX2010006738A (es) | Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos. | |
MX2010006736A (es) | Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos. | |
MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
MX2007008723A (es) | Polipeptidos de yersinia spp y metodos de uso. | |
MX2007008137A (es) | Triazoloftalazinas como inhibidores de pde2. | |
HK1097768A1 (en) | Modified pyrimidine glucocorticoid receptor modulators | |
GEP20094785B (en) | Pyrrolopyrazoles, potent kinase inhibitors | |
WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
EA200702278A1 (ru) | Антитела, специфичные в отношении tgf-бета 1 | |
UA97502C2 (ru) | Кристаллическая твердая основа разагилина | |
PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
TW200716622A (en) | Substituted piperidines | |
TNSN07222A1 (en) | Nematicidal compositions | |
MY173526A (en) | Novel anti-?5?1 antibodies and uses thereof | |
HK1117746A1 (en) | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use | |
MX2010003200A (es) | Composiciones de imatibnib estables. | |
TW200738649A (en) | Calcilytic compounds | |
MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
NZ579478A (en) | Epha3 antibodies for the treatment of solid tumors | |
EA200800713A1 (ru) | Аморфные твёрдые дисперсии | |
WO2008027600A3 (en) | Imatinib compositions | |
TW200716130A (en) | Purified form of tanaproget | |
WO2008150537A3 (en) | Silica particles and methods of making and using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |